FDA Drug Application (022175) for PERTZYE by DIGESTIVE CARE INC

Back to FDA Applications sponsored by DIGESTIVE CARE INC

Application Number022175
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage30,250USP UNITS;8,000USP UNITS;28,750USP UNITS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePERTZYE
Active IngredientPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)



Back to FDA Applications sponsored by DIGESTIVE CARE INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.